Delcath Systems (DCTH) vs Lumexa Imaging (LMRI)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Lumexa Imaging is the larger company by market cap ($1.01 billion vs $533.0 million), about 1.9 times the size. On valuation, Lumexa Imaging trades at a lower forward P/E (11.8x vs 341.3x for Delcath Systems).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | DCTH | LMRI |
|---|---|---|
| Share price | $15.36 | $10.54 |
| Market cap | $532.97M | $1.01B |
| 1-day change | +2.13% | +2.03% |
| YTD return | +52.08% | -43.03% |
| 1-year return | +41.18% | — |
| 5-year return | +63.23% | — |
| Forward P/E | 341.33 | 11.84 |
| EPS (TTM) | $0.01 | $-0.37 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.42 | $19.45 |
| 52-week low | $8.12 | $6.45 |
| Distance from 52-week high | -11.83% | -45.81% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +56.25% | +67.65% |
| Average volume | 479.73K | 430.76K |
| Shares outstanding | 34.70M | 96.07M |
| Employees | 156 | 5,000 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Delcath Systems
DCTH stock →Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
Health Care · Medical/Dental Instruments · 156 employees
About Lumexa Imaging
LMRI stock →Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.
Health Care · Medical Specialities · 5,000 employees
DCTH vs LMRI FAQ
Which is bigger, Delcath Systems or Lumexa Imaging?
Lumexa Imaging (LMRI) is larger, with a market capitalization of $1.01B compared with $532.97M for Delcath Systems (DCTH).
Are Delcath Systems and Lumexa Imaging in the same industry?
Both are in the Health Care sector, but in different industries: Medical/Dental Instruments for Delcath Systems and Medical Specialities for Lumexa Imaging.